JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.54% |
| 2 | Financials | 14.6% |
| 3 | Technology | 12.1% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HNP
4651
DELISTED
Huaneng Power Intl, Inc.
HNP
| $3K | ﹤0.01% |
109
+8
| +8% | +$212 |
2015 Q4
7 quarters
|
|
|
CEZ
4652
DELISTED
VictoryShares Emerging Market Volatility Wtd ETF
CEZ
| $3K | ﹤0.01% |
+102
| New | +$2.95K |
2017 Q3
0 quarters
|
|
|
FCSC
4653
DELISTED
Fibrocell Science Inc.
FCSC
| $3K | ﹤0.01% |
160
+120
| +300% | +$1.94K |
2017 Q2
1 quarter
|
|
4654
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $3K | ﹤0.01% |
111
-780,375
| -100% | -$19.3M |
2015 Q4
7 quarters
|
|
|
CYHHZ
4655
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
| $3K | ﹤0.01% |
245,552
-96,954
| -28% | -$1.39K |
2014 Q1
14 quarters
|
|
4656
DELISTED
Eastman Kodak Company
KODK.WS
| – | – |
0
| – | – |
2015 Q4
7 quarters
|
|
|
CCUR
4657
DELISTED
CCUR Holdings, Inc. Common Stock
CCUR
| $3K | ﹤0.01% |
447
-7,062
| -94% | -$45K |
2017 Q2
1 quarter
|
|
|
XCO
4658
DELISTED
Exco Resources
XCO
| $3K | ﹤0.01% |
2,075
-636
| -23% | -$1.07K |
2016 Q3
4 quarters
|
|
|
OIBR.C
4659
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $3K | ﹤0.01% |
353
| – | – |
2015 Q1
10 quarters
|
|
|
AMFW
4660
DELISTED
AMEC Foster Wheeler plc
AMFW
| $3K | ﹤0.01% |
372
-11,048
| -97% | -$64.6K |
2015 Q3
8 quarters
|
|
4661
DELISTED
China Telecom Corporation, LTD
CHA
| $3K | ﹤0.01% |
68
+9
| +15% | +$441 |
2014 Q4
11 quarters
|
|
4662
Ambarella
AMBA
$2.8B
| $2K | ﹤0.01% |
48
| – | – |
2015 Q4
7 quarters
|
|
|
DRK
4663
DarkHorse Technologies Inc. Common Shares
DRK
$22.9M
| $2K | ﹤0.01% |
+1
| New | +$2.31K |
2017 Q3
0 quarters
|
|
4664
First Busey Corp
BUSE
$2.42B
| $2K | ﹤0.01% |
52
-133,672
| -100% | -$3.91M |
2013 Q2
17 quarters
|
|
4665
MBody AI Ltd. Ordinary Share
MBAI
$47.4M
| $2K | ﹤0.01% |
1
| – | – |
2015 Q4
7 quarters
|
|
4666
iShares CMBS ETF
CMBS
$437M
| $2K | ﹤0.01% |
32
| – | – |
2017 Q1
2 quarters
|
|
4667
Crawford & Co Class A
CRD.A
$591M
| $2K | ﹤0.01% |
158
-685
| -81% | -$5.49K |
2017 Q1
2 quarters
|
|
4668
Crawford & Co Class B
CRD.B
$568M
| $2K | ﹤0.01% |
174
-96
| -36% | -$931 |
2016 Q2
5 quarters
|
|
4669
Cytosorbents Corp
CTSO
$9.64M
| $2K | ﹤0.01% |
14
| – | – |
2015 Q4
7 quarters
|
|
4670
Gabelli Healthcare & Wellness Trust
GRX
$144M
| $2K | ﹤0.01% |
225
| – | – |
2015 Q4
7 quarters
|
|
4671
ProShares Hedge Replication ETF
HDG
$22.3M
| $2K | ﹤0.01% |
45
-100
| -69% | -$4.44K |
2017 Q1
2 quarters
|
|
4672
iRadimed
IRMD
$1.14B
| $2K | ﹤0.01% |
160
| – | – |
2016 Q3
4 quarters
|
|
4673
Kingsway Corp
KWY
$281M
| $2K | ﹤0.01% |
300
| – | – |
2017 Q2
1 quarter
|
|
4674
Cohen & Steers Duration Preferred & Income Fund
LDP
$552M
| $2K | ﹤0.01% |
69
| – | – |
2017 Q2
1 quarter
|
|
4675
Mercer International
MERC
$13.4M
| $2K | ﹤0.01% |
152
-9,554
| -98% | -$107K |
2016 Q1
6 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 501 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 501 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.